Showing results (21-30 of 140) with videos related to
Sort By:
Pageof 14
Pediatric Blood & Cancer|November 5, 2010
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecanBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Hybridoma and Hybridomics|September 27, 2003
Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapyNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.International Journal of Cancer|December 18, 2023
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastomaJaume Mora, Shakeel Modak, Joyce Kinsey, et al.Clinical Nuclear Medicine|February 16, 2026
Early Detection of Neuroblastoma Recurrence on 18F mFBG PETNeeta Pandit-Taskar, Anita Price, Gerald Behr, et al.Hybridoma and Hybridomics|February 8, 2003
Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteinsNai-Kong V Cheung, Hong-Fen Guo, Shakeel Modak, et al.International Journal of Cancer|July 16, 2025
Rapid COJEC without myeloablative therapy for high-risk neuroblastomaBrian H Kushner, Ellen M Basu, Fiorella Iglesias Cardenas, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.Cancer|June 17, 2006
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastomaBrian H Kushner, Amy Budnick, Kim Kramer, et al.Leukemia Research|May 3, 2005
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucanShakeel Modak, Guenther Koehne, Andrew Vickers, et al.Journal of Pediatric Hematology/Oncology|August 18, 2017
Bevacizumab-associated Bowel Microperforation in a Patient With NeuroblastomaRachel Glincher, Anita P Price, Michael P LaQuaglia, et al.Pageof 14